CONQUER magazine's Guide for
Patients with Lung Cancer
CONQUER is pleased to present this 4-part series of articles on non–small-cell lung cancer, the most frequently occurring type. Written for patients by an oncologist and a nurse practitioner, each of the Patient’s Guides addresses a topic often confronted during the course of therapy: Staging; Treatment; Biomarker Testing; and an Overview of the Lung Cancer Patient Journey. Also included is an easy-to-navigate “road map” that highlights important treatment milestones. The series was written with the financial support of Novartis Pharmaceuticals.
Blanca A. Ledezma, MSN, NP
Nurse Practitioner, Oncology & Hematology
UCLA Santa Monica Hematology Oncology, California
Edward B. Garon, MD
Medical Oncologist, Oncology & Hematology
David Geffen School of Medicine at UCLA, California
Articles in this Series
- Staging of Non–Small-Cell Lung Cancer: A Guide for Patients
Knowing the stage of lung cancer helps oncologists to plan the best treatment plan for each patient. This first article in the series explains how the most common type of lung cancer is staged.
- Treatment of Non–Small-Cell Lung Cancer: A Guide for Patients
In the second article of this 4-part series, the authors present an overview of the current treatment landscape for NSCLC, including a description of the most often used treatments and common questions that patients can ask their providers.
- Biomarker Testing in Non–Small-Cell Lung Cancer: A Guide for Patients
Non–small-cell lung cancer, or NSCLC, is the most common form of lung cancer, accounting for about 80% to 85% of all lung cancer cases in the United States.
- The Patient Journey in Non–Small-Cell Lung Cancer: An Overview
In this last part of the series, we examine the full patient journey, from diagnosis through treatment, and provide a list of questions for patients to ask their doctors for more information.